Get the Stockscreener App
38.13
0.83%
-0.32
Septerna Inc stock is traded at $38.13, with a volume of 293.04K.
It is down -0.83% in the last 24 hours and down -5.90% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$38.45
Open:
$38.41
24h Volume:
293.04K
Relative Volume:
0.67
Market Cap:
$1.78B
Revenue:
$45.95M
Net Income/Loss:
$-48.88M
P/E Ratio:
-34.26
EPS:
-1.1129
Net Cash Flow:
$109.67M
1W Performance:
-3.47%
1M Performance:
-5.90%
6M Performance:
+62.67%
1Y Performance:
+125.49%
1-Day Range:
$37.49
$38.80
1-Week Range:
$36.98
$41.09
52-Week Range:
$16.21
$51.10
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
38.13 | 1.78B | 45.95M | -48.88M | 109.67M | -1.1129 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | Raymond James | Strong Buy |
| Dec-15-25 | Initiated | Truist | Buy |
| Nov-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
Septerna, Inc. (SEPN) Investor Outlook: Strong Buy Ratings Signal 37% Potential Upside - DirectorsTalk Interviews
Septerna, Inc.Common Stock (NQ: SEPN - The Chronicle-Journal
Septerna (SEPN) Heads To Healthcare Conferences, Is The Valuation Already Too Rich? - finance.yahoo.com
Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Septerna's CMO Rajiv Patni Granted 275,000 Stock Options with 10-Year Expiry - Kalkine Media
Septerna (SEPN) awards CMO 275,000 options at $37.37 - Stock Titan
Septerna Announces Inducement Grant Under Nasdaq Listing Rule - TradingView
A new medical chief gets an option to buy up to 275,000 Septerna shares at $37.37 - Stock Titan
Wells Fargo Sticks to Their Buy Rating for Septerna, Inc. (SEPN) - The Globe and Mail
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds By Investing.com - Investing.com Canada
Septerna at Cantor Fitzgerald conference: pipeline broadens, cash holds - Investing.com India
Septerna (SEPN) Q2 2026 Earnings: $0.29 Per-Share Loss Beats Estimates by 33.26% as Stock Gains 3.28%Performance Review - dars.gov.et
Septerna at Wells Fargo conference: platform bets and pipeline catalysts By Investing.com - Investing.com Canada
Septerna SVP Daniel Long sells $126,077 in company stock By Investing.com - Investing.com South Africa
Septerna SVP Daniel Long sells $126,077 in company stock - investing.com
New Septerna (SEPN) chief medical officer reports zero share holdings - Stock Titan
Septerna to Participate in Upcoming Investor Conferences - manilatimes.net
Septerna (SEPN) Declines 1.95% to $38.15, Approaching Key Support at $36.24Parabolic SAR - vinanet.vn
Septerna Inc Q2 Income From Operations USD -1 - moomoo.com
Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed? - sahmcapital.com
Septerna stock soars 315% on Novo Nordisk deal and key drug milestones - Pluang
Septerna appoints Rajiv Patni as chief medical officer By Investing.com - Investing.com Canada
Septerna Appoints Rajiv Patni as Chief Medical Officer - TipRanks
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - The Manila Times
Septerna (SEPN) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison in the Latest Reading; Market Response: The Share Price Adds 1.30% in the Latest SessionManagement Tone Analysis - dars.gov.et
Septerna (SEPN) Shares: Finishes 2.10% Higher at $40.84 for the Current Session; Immediate View: Support at $38.80 and Resistance at $42.88 Frame the Range in Latest TradingStandard Deviation - vinanet.vn
Driehaus Capital Management Expands Septerna Inc (SEPN) Stake in Second Quarter - GuruFocus
Septerna (NASDAQ:SEPN) Stock Price Down 8%Time to Sell? - MarketBeat
Analysts Offer Insights on NA Companies: Cerebras Systems, Inc. Class A (CBRS), Septerna, Inc. (SEPN) and TWFG, Inc. Class A (TWFG) - theglobeandmail.com
SEPN Maintained by JP Morgan -- Price Target Raised to $48 - GuruFocus
Septerna (NASDAQ:SEPN) Price Target Raised to $48.00 - MarketBeat
J.P. Morgan Maintains Septerna(SEPN.US) With Buy Rating, Raises Target Price to $48 - Moomoo
SEPTERNA, INC. : JP MORGAN RAISES TARGET PRICE TO $48 FROM $38 - Bitget
4,211,659 Shares in Septerna, Inc. $SEPN Acquired by Trv Gp Vi LLC - MarketBeat
Trv Gp V LLC Takes Position in Septerna, Inc. $SEPN - MarketBeat
Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst - The Globe and Mail
37,700 Shares in Septerna, Inc. $SEPN Purchased by Renaissance Technologies LLC - MarketBeat
Ra Capital Management sells $63.45m in Septerna stock By Investing.com - Investing.com Australia
Ra Capital Management sells $63.45m in Septerna stock - Investing.com
Septerna(SEPN.US) 10% Shareholder Sells US$7.4 Million in Common Stock - Moomoo
Third Rock Ventures V, L.P. director sells $7.4m Septerna shares - Investing.com South Africa
RA Capital Management Offloads 1.49 Million Septerna Shares at $42.50 Each - Kalkine Media
Septerna (SEPN): RA Capital funds disclose sale of 1.49M common shares - Stock Titan
Form 4: Third Rock Ventures reports acquisition/exercise transactions in SEPN - Stock Titan
RA Capital group (SEPN) discloses 11.8% Septerna stake and major block sales - Stock Titan
HC Wainwright Predicts Septerna's Q3 Earnings (NASDAQ:SEPN) - MarketBeat
Driehaus Capital Management (SEPN) discloses 4.43M-share Septerna stake in 13G/A - Stock Titan
Septerna (NASDAQ:SEPN) COO Elizabeth Bhatt Sells 25,000 Shares of Stock - MarketBeat
Septerna president & COO Elizabeth Bhatt disposes of $1.1m in stock - Investing.com Nigeria
Septerna Inc Stock (SEPN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):